Search results
Yingli Ma, Ph.D. Chief Technology Officer. Dr. Ma has more than 15 years of research, technology and drug discovery experience in pharma and biotech settings.
Chief Technology Officer at Structure Therapeutics. Show contact. Yingli Ma has a diverse work experience spanning various roles in the pharmaceutical and biotechnology industry. They started their career at Rockefeller University as a Postdoctoral Associate from August 2005 to March 2009.
Ma Yingli is Chief Technology Officer at Structure Therapeutics Inc. See Ma Yingli's compensation, career history, education, & memberships.
Jan 15, 2020 · Here, we report the structure-guided discovery of a single-domain antibody (sdAb) agonist JN241-9, based on the cocrystal structure of APJ with an sdAb antagonist JN241, the first cocrystal structure of a class A G protein–coupled receptor (GPCR) with a functional antibody.
Yingli Ma. General Manager & President, ShouTi Basecamp Bio at ShouTi. Show contact. Dr. Ma has more than 15 years of research, technology, and drug discovery experience in pharma and biotech settings.
Explore Authentic Ma Yingli Stock Photos & Images For Your Project Or Campaign. Less Searching, More Finding With Getty Images.
Feb 11, 2020 · Recent development in cryo-electron microscopy (cryo-EM) has enabled the determination of full-length class B GPCR structures in complex with their peptide ligand and G protein complex. 9, 10,...
